Crofab Articles
Bayer unit gets rights to KYTHERA’s adipolytic dermatology agent in up to $373 million deal; BTG to regain product rights from Nycomed
31 August 2010
BTG on track for savings from Protherics buy
6 April 2009
Protherics rockets on bid approaches
1 September 2008
Correction: Protherics
23 June 2008
Protherics falls deeper into loss in fiscal 2007/8
16 June 2008
Protherics upbeat despite higher losses
18 December 2006
Protherics: healthy cash flow after CytoFab deal
17 April 2006
Protherics swings to loss in fiscal first half
19 December 2005
Fougera's CroFab celebrates 5th anniversary
22 August 2005
FDA approves third-party production of Protherics' CroFab
24 January 2005
Protherics sees profit for six-month period
20 December 2004
Protherics reports first year of profit for 2003
31 May 2004
Protherics charms profit from snake venom drug
8 December 2003
Protherics swings to loss but future bright
9 June 2003
Protherics acquires Enact and makes L3M placing
12 May 2003
Protherics now in profit
3 June 2002
Protherics' angiotensin vaccine promising
1 April 2002
Protherics launches DigiFab in USA
11 March 2002
Tally of NCEs in 2001 lends credence to talk of R&D productivity
21 January 2002
Stock Commentary - Europe
13 December 2001
The UK's Protherics moves into the black
12 December 2001
Protherics sells CAMD to Tularik
13 July 2001
Stock Commentary - Europe
17 May 2001
CroFab launched in USA by Savage
1 February 2001
Stock Commentary - Europe
11 January 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
Protherics cuts loss, readies CroFAb for US launch
14 December 2000
Stock Commentary Europe
19 October 2000
Stock Commentary Europe
12 October 2000
Protherics wins first approval for CroFab
10 October 2000
Showing 1-31 of 31 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
